TVRD
Financials
- Market Capitalization 24.14 M
- Employee 12
- Founded 2017
- CEO N/A
- Website www.tvarditherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J2QYS9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4491 |  EVAX Evaxion A/S - American Depositary Share | 3.06 USD | -2.86% | -8.93% | +8.90% | -7.83% | 25.52 M USD | ||
| 4501 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.51 USD | -4.92% | -1.57% | +5.91% | +225.97% | 25.05 M USD | ||
| 4510 |  MRKR Marker Therapeutics, Inc. - Common Stock | 1.42 USD | -2.74% | +1.43% | +19.33% | +44.90% | 23.68 M USD | ||
| 4512 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 2.52 USD | -0.79% | -1.95% | -0.79% | -19.75% | 23.82 M USD |
Frequently asked questions about Tvardi Therapeutics, Inc. Common Stock
What is the Tvardi Therapeutics, Inc. Common Stock stock price today?
The current price of Tvardi Therapeutics, Inc. Common Stock (TVRD) is 1.81. Over the past 24 hours, the stock has changed by 0.00%. Follow the TVRD chart for real-time price dynamics.
What is the stock ticker of Tvardi Therapeutics, Inc. Common Stock?
Tvardi Therapeutics, Inc. Common Stock trades under the ticker TVRD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Tvardi Therapeutics, Inc. Common Stock stock going up?
TVRD has changed by -2.16% over the last week, -26.42% over the last month, and -49.72% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Tvardi Therapeutics, Inc. Common Stock?
Tvardi Therapeutics, Inc. Common Stock currently has a market capitalization of 24.14 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Tvardi Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Tvardi Therapeutics, Inc. Common Stock reported earnings of -0.69 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Tvardi Therapeutics, Inc. Common Stock net income for the last quarter?
Tvardi Therapeutics, Inc. Common Stock reported net income of -6.46 M for the last quarter. The previous quarter showed -6.8 M, which means net income changed by +5.10%.
Is Tvardi Therapeutics, Inc. Common Stock a good dividend stock?
Tvardi Therapeutics, Inc. Common Stock currently has a dividend yield of 0%. Previously, the dividend yield was 0%, compared with 0% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Tvardi Therapeutics, Inc. Common Stock have?
As of the latest available data, Tvardi Therapeutics, Inc. Common Stock has 12 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Tvardi Therapeutics, Inc. Common Stock stock?
You can buy Tvardi Therapeutics, Inc. Common Stock (TVRD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Tvardi Therapeutics, Inc. Common Stock stock?
Investing in Tvardi Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TVRD chart and related analysis on metatrader.com as part of your research.